Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It reads as if APDN is not involved with Takis.
This has happened numerous times before: Theracan, Organic cotton, fertilizers, etc.
Hayward announces a collaboration but doesn’t announce when it unwinds.
AND, Sanjay’s email didn’t inform us of that.
He just said they were waiting to hear from Takis.
If you are in a partnership with someone, wouldn’t you know on a daily basis?
Why not send an email re: this:
“Since You told analyst Wainwright you were shipping the Covid 19 test kits, why wasn’t a press release made to the general investors? How many orders have been received for the kits? Who is manufacturing them?
What is the sales price?”
H.C. Wainwright Initiates a Buy Rating on Applied DNA Sciences (APDN)
Howard Kim Howard Kim
9 hours ago
In a report released today, Yi Chen from H.C. Wainwright initiated coverage with a Buy rating on Applied DNA Sciences (APDN) and a price target of $18.00. The company’s shares closed last Wednesday at $7.75.
According to TipRanks.com, Chen is a 5-star analyst with an average return of 16.0% and a 48.1% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $19.50.
That’s why I quit asking Sanjay anything.
When you really look at what he’s saying, it’s quite disturbing.
If the company makes a statement that they will update by June, then Hayward should explain in a press release on or before the June 30 date.
The press release should include concise information about where the testing stands as well as a timeline for phase III tests as promised.
Sadly, Sanjays response is a long winded way of saying absolutely nothing.
The only contact I have had was a Maxim hawker trying to dump more stock on me.
Reithera i meant
This is interesting. Reithers and Takis have the same address:
100 Via di Romano, Rome.
They also have the same number of employees.
If Takis Pharma was entering human trials in Brazil, it does seem almost certain there would have been a press release by APDN.
Thanks for putting that together.
It appears the animal test were a home run. Human testing in Brazil also makes sense.
I think the biomedical research in Curitiba, Brazil has far less red tape and restrictions.
Those companies are at the forefront of stem cell therapies.
Yes, the Takis Covid 19 animal testing was to be completed mid June with results out before end of June. That’s now.
In February of 2020, Nutrition21 was the first company in the dietary supplement industry to adopt CertainT, a technology solution by Applied DNA Sciences designed to protect the IP of ingredient suppliers. This state-of-the-art solution provides Nutrition21 the ability to identify its ingredients through the global supply chain from raw material to finished products in retail and e-commerce. CertainT supports Nutrition21's investment in brand and IP protection for its ingredients and its customers' final products.
Except. Maxim is on the phone all day selling more shares.
It’s the only way Hayward has ever made money. Sell more shares.
No news from Takis for weeks now except them taking on a partner.
It looks like he exercised the options and then sold them., helps to lower the basis of the shares he owns.
It was a grant from a known scientific foundation. The amount is small, but even I have to see this as a good thing. The toxicity tests are important.
It will be interesting in the coming mints to see which company can address the over or hyper production of anti bodies experienced by young children. Perhaps the Takis/APDN novel vaccine won’t produce a negative response.
The grant is for toxicity tests.
The death spiral of a 300% dilution.
So predictable.
True . If you cared about shareholder value.
Hayward has traditionally done his giveaways at bargain prices to reel in the next fish.
This death spiral in the stock price happens every time he registers new stock for sale.
Also, expect a long deadly silence from Hayward on Takis.
Something went wrong there and I don’t like the Italian news article. Been here, done this.
He got this board to vote for his lates $50 million stock offering.
A real rip-off and massive dilution to current shareholders.
Now he has the nerve to go back to Maxim and post about it.
Hayward can never go 6 months without announcing another massive dilution.
Call Sanjay. See if you can decipher the gobbledegook.
I really wish against all odds that I am wrong this time.this is a case where I sincerely want to be wrong.
It’s just that for many years , Hayward announces a collaboration or agreement it creates a lot of interest. He even managed to get Takis/APDN into the NY Post .
Then we read Takis has taken on another partner for funding. We hsve to dig this info out and hopefully read Italian.
This happened with Turkish Fertilizer, Organic Cotton, Food and packaging.
One investor had to drive to a cotton farm to verify that APDN was not marking their cotton.
McSharkey has to decipher Turkish and Nigerian government info to unravel all the hype over fertilizers.
3 weeks ago APDN got fast track approval for their Covid 19 test. Then nothing.
Colorcon developments/contracts? None.
This is an unending pattern of Hayward’s. The only way I have ever seen him create cash flow is the constant issuance of more shares, subsequently threats of delisting, then 40/1 reverse splits.
All this for years now. Repeating, repeating ad infinitum.
We’re still waiting on Techmer, Palmetto, leather, auto marking, fertilizers, Cotton, Colorcon.
Been waiting for years. Typically there are news releases and a lot of hype. Then nothing. Hayward has done this over and over for twenty plus years.
As far as Tyne and Takis go, this is Hayward’s latest Hype. When he issues an open ended stock sale and starts courting Maxxim, watch out. The only way Hayward has generated positive cash flow in 20 years is by selling more stock.
Ask Sharky and others. This is a never ending broken record.
There has never been a contract or agreement that has ever generated a profit.
Right Shark. Maxim is just trying to reel in some new unwary investors to buy up Hayward’s latest $50 million shelf offering.
As far as Takis goes, it seems to me that Astra Zeneca and possibly 5 other major groups will have a vaccine before Takis starts any potential human trials.
The Covid19 test kits used at the hospital trials in StonyBrook? That sounded good, however, there are already several kits being used worldwide. Why develop this one now? Those details are unknown.
Deja Vu, I am very sorry to say. Responses from Sanjay are tailor scripted to look good, but upon analysis, offer no insights. Basically they are vapid.
It seems that news on the Covid19 test kits and the Tyne kits is past due.
According to Hayward they already sold 2000 kits to Tyne last December. No revenue and no further news.
They did extensive testing of the Covid19 kit at Stony Brook hospital, then got FDA rapid deployment.
The results? No news for weeks.
So am I saying this is an established pattern for Hayward? well, ...yes.
This Maxim symposium is just another means to sell additional stock .
Maxim brokers stock and warrant programs for struggling companies.
As soon as the stock went up in value, Hayward had the board approve a shelf offering diluting current shareholders by at least 100%. He has done this over 20 times before. The only way Hayward has ever created cash flow is thruwdution of shares.
We have seen this run up and crash many times before.
Historically for Hayward, when he registers a new stock offering, it means no good news on the horizon.
I haven’t seen him pull a rabbit from the hat yet.
Pill marking, fertilizer, document marking, Synthetics, autos, home kits, currency, marijuana, wool, leather, designer goods, etc, etc, etc.
We oldtimers have seen it all. The rage du jour? Covid19.
Hayward has never, ever been able to generate any profitable enterprise in the last 20 years.
This latest filing is now part of a long, long broken record.
The only way Hayward has ever raised a dime is by issuing more stock.
This Maxim Conference is a shill to sell more to institutional investors.
We still don’t know if there are any orders for the test kit or if Takis will ever have a vaccine.
Hi Shark. No idea how long it’s been up.
However, it seems to be at odds with the Tyne purchase PR.
I thought they had purchased the kits outright from APDN/LineaRX.
But, as you said, those sales never showed up in the financials.
Another material event simply ignored by Hayward.??
I think that estimate is conservative.
You also have Takis and Colorcon.
Jmho, but I believe the pps will be many multiples of your 32 est.
Then Hayward will finally have his billion dollar enterprise.
2000 tests per day with a single machine sound like the answer to 99% of companies.
And in 1 hour.
“Takis was allegedly exploring options with US-based LineaRx. However, the company requires the Italian government’s support and alliances with international bodies to further develop the vaccine, added Aurisicchio.”
It’s this paragraph that has me confused. Is the author of the article disputing the APDN/Takis agreement??
Not sure what to make of this:
https://www.pharmaceutical-technology.com/news/italy-coronavirus-vaccine-candidate/
I wouldn’t be surprised to see terminal cases injected this week.
The NY Post article quotes Takis that they have jumped trials in humans to this summer.
Or almost immediately.
https://nypost.com/2020/05/06/scientists-neutralize-coronavirus-cells-with-mice-antibodies/
I think because of the NY Post article detailing the APDN/Takis breakthrough, any conference call would turn into a circus.
Apparently there is now a cure. Finally.
I think APDN will break 100 tomorrow.
I previously posted the human trials would start this summer, not being delayed. I now expect the human trials to begin immediately.
The warrants are being exercised to cover margin calls on short positions.
A bunch of shorts are having margin calls today, in fact they have to cover in the next hour before trading close.
I assume these are shares borrowed against warrants under 5 bucks.
What a disaster if the current pps holds.
I would think since animals are being infected, that these results are so significant, the EU will fast track to human volunteers much sooner.
Press release due out tomorrow on Covid19 rapid test .
Of course they are using an approved system.
APDN is running tests there for their novel test kit.
SARS and Mers came and went without a pandemic.
Not comparable to Covid19 and this sense of urgency.
They had better find a vaccine now that can be easily changed for future mutations.
Each one could get worse.
True, there are no 100% effective vaccines for the various flu strains.
No need or sars vaccines.
Anyone of the several Coronavirus vaccines starting human testing will not work for some high percentage of the population. But, the greatly curb the overal picture more positively. If APDN/Takis vaccine is highly effective,
Then you can name your price for this stock.
APDN covid19 test kit results should be released tomorrow as stated in press release.